Asahi Kasei Corporate Venture Capital is the famous VC, which was founded in 2008. The venture was found in North America in United States. The main office of represented VC is situated in the Menlo Park.
Among the most popular fund investment industries, there are Biotechnology, Therapeutics. Among the most popular portfolio startups of the fund, we may highlight Feldan Therapeutics, Hazel Technologies. The fund has no exact preference in some founders of portfolio startups. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Canada.
The fund is constantly included in less than 2 deals per year. The important activity for fund was in 2018. The common things for fund are deals in the range of 10 - 50 millions dollars.
The typical case for the fund is to invest in rounds with 6-7 participants. Despite the Asahi Kasei Corporate Venture Capital, startups are often financed by Valley Oak Investments, Rhapsody Venture Partners, VentureWell. The meaningful sponsors for the fund in investment in the same round are Valley Oak Investments, Stonebridge Ventures, Serra Ventures. In the next rounds fund is usually obtained by National Institutes of Health.
Funds with similar focus
|Beijing Yisheng Innovation Technology||Beijing, Beijing, China|
|DIventures||Switzerland, Zürich, Zurich|
|InterVest Co.||Seoul, Seoul-t'ukpyolsi, South Korea|
|Kitara Capital||Masqat, Muscat, Oman|
|Mad'a Investment Company||Ar Riyad, Riyadh, Saudi Arabia|
|Open Source Syndicate||California, San Francisco, United States|
|Shanghai Shangchuang Xinwei Investment Management||-|
|Steadfast Financial||New York, New York, United States|
|$10M||16 Jun 2022||San Francisco, California, United States|
|$26M||03 Feb 2022||Oakland, California, United States|
|$25M||06 May 2021||Miamisburg, Ohio, United States|
|$70M||13 Apr 2021||Chicago, Illinois, United States|
|$55M||24 Mar 2021||Redwood City, California, United States|
|$13M||12 Aug 2019||Chicago, Illinois, United States|
|$13M||18 Sep 2018||Quebec|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.